Analysis of New NAD-cleavage Enzymes Involved in Signal Transduction System

信号转导系统中涉及的新型 NAD 裂解酶的分析

基本信息

项目摘要

The human cell surface antigen CD38, which has an amino acid sequence homologous to Aplysia ADP-ribosyl cyclase, is a 46-kDa type II glycoprotein with a single-transmembrane domain. We previously demonstrated that the extracellular domain of CD38 exhibits NAD^+ glycohydrolase (NADase) activity and that the ecto-form NADase activity induced by all-trans retinoic acid (RA) in HL-60 cells is due to CD38. CD38 catalyzes not only the hydrolysis of NAD^+ but also the formation and hydrolysis of cyclic ADP-ribose, which is a novel candidate that mediates Ca^<2+> release from intracellular Ca^<2+> stores. In the present study, we obtained the following findings. 1. Stimulation of RA-differentiated HL-60 cells with anti-CD38 monoclonal antibodies (mAbs) induced rapid tyrosine phosphorylation of cellular proteins with the molecular weights of 120,000,87,000 and 77,000. One of the prominent phosphorylated proteins was identified as the c-cbl proto-oncogene product, p120^<c-cbl>.2. Superoxide formation in response to formyl-Met-Leu-Phe was markedly enhanced by the anti-CD38 mAbs in the differentiated HL-60 cells. 3. The epitopes recognized by these agonistic mAbs stimulating protein tyrosine phosphorylation were all mapped on the same carboxyl-terminal sequence of CD38, and the same sequence was also required for its ecto-NADase activity. 4. Fcgamma-II receptors appeared to be involved in the signal transduction pathway mediated through the agonistic anti-CD38 mAb-induced tyrosine phosphorylation of cellular proteins. 5. The expression of CD38 mRNA was mediated through nuclear RA receptors ; a RA receptor-responsive element was present in the first intron of CD38 gene.
人细胞表面抗原 CD38 具有与海兔 ADP-核糖基环化酶同源的氨基酸序列,是一种具有单跨膜结构域的 46 kDa II 型糖蛋白。我们之前证明CD38的胞外结构域表现出NAD^+糖水解酶(NADase)活性,并且HL-60细胞中全反式视黄酸(RA)诱导的外型NADase活性是由于CD38所致。 CD38不仅催化NAD^+的水解,而且还催化环状ADP-核糖的形成和水解,这是介导细胞内Ca^2+储存的Ca^2+释放的新候选者。在本研究中,我们获得了以下发现。 1.用抗CD38单克隆抗体(mAb)刺激RA分化的HL-60细胞,诱导分子量为120,000、87,000和77,000的细胞蛋白快速酪氨酸磷酸化。一种重要的磷酸化蛋白被鉴定为 c-cbl 原癌基因产物 p120^<c-cbl>.2。在分化的 HL-60 细胞中,抗​​ CD38 mAb 显着增强了对甲酰基 Met-Leu-Phe 反应的超氧化物形成。 3.这些激动性单克隆抗体刺激蛋白酪氨酸磷酸化所识别的表位都定位在CD38的相同羧基末端序列上,并且其胞外NAD酶活性也需要相同的序列。 4. Fcgamma-II 受体似乎参与通过激动性抗 CD38 mAb 诱导的细胞蛋白酪氨酸磷酸化介导的信号转导途径。 5. CD38 mRNA的表达是通过核RA受体介导的; CD38基因的第一个内含子中存在RA受体反应元件。

项目成果

期刊论文数量(31)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KATADA Toshiaki其他文献

KATADA Toshiaki的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KATADA Toshiaki', 18)}}的其他基金

Identification of signaling pathways involved in fungal pathogenicity and search for novel targets for antifungal drugs
鉴定真菌致病性信号通路并寻找抗真菌药物新靶点
  • 批准号:
    20K06550
  • 财政年份:
    2020
  • 资助金额:
    $ 4.35万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Nutrient response mediated by a TRIM-NHL protein
TRIM-NHL 蛋白介导的营养反应
  • 批准号:
    16K14693
  • 财政年份:
    2016
  • 资助金额:
    $ 4.35万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
A novel signal transduction pathway which regulates the structure of P-body and the dynamics of ARE-mRNAs
调节 P-body 结构和 ARE-mRNA 动态的新型信号转导途径
  • 批准号:
    22659015
  • 财政年份:
    2010
  • 资助金额:
    $ 4.35万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Regulation of intracellular vesicle transport by small GTPase cycles
小 GTP 酶循环调节细胞内囊泡运输
  • 批准号:
    20247011
  • 财政年份:
    2008
  • 资助金额:
    $ 4.35万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Membrane-Transport Signaling Involving the GTPase Cycle of G proteins
涉及 G 蛋白 GTP 酶循环的膜运输信号转导
  • 批准号:
    18207008
  • 财政年份:
    2006
  • 资助金额:
    $ 4.35万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Functional analysis of atypical G proteins involved in cell signaling network
参与细胞信号网络的非典型G蛋白的功能分析
  • 批准号:
    17079002
  • 财政年份:
    2005
  • 资助金额:
    $ 4.35万
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
New research initiatives in the study of G-protein signaling systems integrating cell communication network
整合细胞通讯网络的G蛋白信号系统研究新举措
  • 批准号:
    17079001
  • 财政年份:
    2005
  • 资助金额:
    $ 4.35万
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
The structure and function of a novel G protein family regulating eukaryotic mRNA dynamics
调节真核mRNA动态的新型G蛋白家族的结构和功能
  • 批准号:
    13854025
  • 财政年份:
    2001
  • 资助金额:
    $ 4.35万
  • 项目类别:
    Grant-in-Aid for Scientific Research (S)
G protein-dependent vectorial transportation of receptors, ion channels, and transporters
受体、离子通道和转运蛋白的 G 蛋白依赖性载体运输
  • 批准号:
    12144202
  • 财政年份:
    2000
  • 资助金额:
    $ 4.35万
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
Physiological roles of cell surface ecto-enzymes
细胞表面胞外酶的生理作用
  • 批准号:
    11694249
  • 财政年份:
    1999
  • 资助金额:
    $ 4.35万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).

相似海外基金

Delineating how nucleic acid sensing in tumor cells regulate anti-tumor immune responses
描述肿瘤细胞中的核酸传感如何调节抗肿瘤免疫反应
  • 批准号:
    10626284
  • 财政年份:
    2023
  • 资助金额:
    $ 4.35万
  • 项目类别:
The role of CD38 in immunity to tuberculosis
CD38在结核免疫中的作用
  • 批准号:
    10727585
  • 财政年份:
    2023
  • 资助金额:
    $ 4.35万
  • 项目类别:
Role of astrocytes and astrocytic CD38 in spinal opioid signaling
星形胶质细胞和星形胶质细胞 CD38 在脊髓阿片信号传导中的作用
  • 批准号:
    10452235
  • 财政年份:
    2022
  • 资助金额:
    $ 4.35万
  • 项目类别:
Development of a potent and selective oral ENPP1 inhibitor for oncology
开发用于肿瘤学的有效且选择性口服 ENPP1 抑制剂
  • 批准号:
    10705273
  • 财政年份:
    2022
  • 资助金额:
    $ 4.35万
  • 项目类别:
Functional roles of GOF TP53 mutations in metastasis and immunosuppression of head and neck cancers
GOF TP53突变在头颈癌转移和免疫抑制中的功能作用
  • 批准号:
    10617289
  • 财政年份:
    2022
  • 资助金额:
    $ 4.35万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了